Amoxapine

   
Google
 
Web NewDrugInformation.com

Amoxapine


Drug - Amoxapine
The trade name of the product as shown on the labeling.

Dosage - TABLET; ORAL
The product dosage form and route separated by a semi-colon.

Active Ingredient(s) - Amoxapine
Multiple ingredients are in alphabetical order.

Strength - 100MG
The potency of the active ingredient(s), Amoxapine. May repeat for multiple part products.

Applicant - WATSON LABS
The firm name holding legal responsibility for Amoxapine. The firm name is condensed to a maximum twenty character unique string.

New Drug Application (NDA) Number - 072690
The FDA assigned number to Amoxapine. Format is nnnnnn.

Product Number - 001
The FDA assigned number to identify Amoxapine. Each strength is a separate product. May repeat for multiple part products. Format is nnn.

Therapeutic Equivalence (TE) Code - AB
The TE Code indicates the therapeutic equivalence rating of generic to innovator Rx products.

Approval Date - Aug 28, 1992
The date Amoxapine was approved as stated in the FDA approval letter to the applicant. The format is Mmm dd, yyyy. Products approved prior to the January 1, 1982 contain the phrase: "Approved prior to Jan 1, 1982".

Reference Listed Drug (RLD) - No
The pioneer or innovator of Amoxapine. The RLD identifies the product Abbreviated New Drug Applications (ANDA) use as a reference. Format is Yes or No.

Type - RX
The group or category of approved drugs Amoxapine is in. Format is RX, OTC, DISCN.

Applicant Full Name - Watson Laboratories Inc
The full name of the firm holding legal responsibility for the new application of Amoxapine.

Amoxapine